In addition, the Kaplan–Meier survival curve analysis showed that high mRNA expression of SCEL was significantly correlated with poor overall survival (OS) (P = 0.035) and shorter progression-free survival (PFS) (P = 0.026) of BC patients in TCGA BRCA dataset (Fig. 2C). The gene discussed is SCEL; the disease is breast cancer.